A poor performer with a good prognosis?

Co-founder of the Switzer Report
Print This Post A A A

The saying that “every dog has its day” doesn’t always apply in markets because some companies are just so inept that they end up on the corporate scrap heap. So it is with much trepidation that I punch into the keyboard these words suggesting an investment thesis to consider Primary Health Care (PRY).

Primary has had a horror run, and as the following share price graph depicts, has been a dog for investors.

Primary Health Care (PRY) – 11/13 to 11/18

Also from this edition